Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot takes over sperm injection in IVF lab trial

NCT ID NCT06074835

Knowledge-focused Sponsor: Conceivable Life Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a robotic assistant to automate key steps in the IVF lab, such as preparing sperm and eggs, injecting sperm into eggs (ICSI), and freezing embryos. Researchers compared the robot's performance to standard manual methods using eggs and embryos from 42 couples undergoing fertility treatment. The goal was to see if automation could make lab work more efficient and consistent, not necessarily to improve pregnancy rates.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Robotic assistant device for gamete preparation, ICSI, embryo culture, and vitrification
What this could lead to
If successful, this could lead to more consistent and efficient IVF lab procedures, potentially reducing costs and easing the workload for embryologists.
What could go wrong
This is a small, early proof-of-concept study with only 42 participants. It focuses on lab automation feasibility, not on improving pregnancy or live birth rates, so benefits for patients are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

42 people

The number who actually took part.

Started

Oct 2023

Finished

Oct 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Medical indication to perform ICSI. * Informed consent signed by the patients before treatment. * Medical indication for the use of autologous or donor oocytes. * Medical indication for the use of autologous or donor sperm. * Motile sperm. Exclusion Criteria: * Recurrent pregnancy loss. * Previous history of total fertilization failure. * Surgical sperm retrieval. * Severe male factor infertility. * Known semen liquefaction problems. * Any other case abnormalities that could potentially reduce success rates according to the criteria of the senior embryologist in charge.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Infertility are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Infertility

Contacts and locations

Locations

  • Hope Fertility Centre, Guadalajara

    Guadalajara, Jalisco, 44630, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.